At a January 9 seminar in Hanoi, CMC outlined proposals to widen market space for Vietnamese-made technology, urging reforms ...
COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including planned 2026 key corporate milestones.
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients ...
Biopharma enters 2026 amid continuing scientific progress and accelerating deal activity, yet its business model is under pressure across every facet of the value chain. Investors are taking note: ...
Grow where your feet can stand. When resources are limited, and we’re trying to balance them against growth, we keep it ...
Explore facts behind the Signature Inc. scam search, including verified details on the company’s business model, employee ...
The latest update is out from Actelis Networks, Inc. ( (ASNS)). On December 15, 2025, Actelis Networks, Inc. released a corporate presentation on its website intended for use in investor and analyst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback